We are live on ! Find out more
FLNA

Filana Therapeutics

51 hedge funds and large institutions have $18.2M invested in Filana Therapeutics in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 7

105% more call options, than puts

Call options by funds: $1.78M | Put options by funds: $867K

92% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 12

28% more funds holding

Funds holding: 4051 (+11)

0.11% less ownership

Funds ownership: 24.31%24.19% (-0.11%)

27% less capital invested

Capital invested by funds: $24.8M → $18.2M (-$6.62M)

Holders
51
Holders Change
+11
Holders Change %
+27.5%
% of All Funds
1.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
17
Reduced
7
Closed
12
Calls
$1.78M
Puts
$867K
Net Calls
+$909K
Net Calls Change
-$959K
Name Holding Trade Value Shares
Change
Change in
Stake
Squarepoint
26
Squarepoint
New York
$57K +$84.2K +18,554 New
SFI
27
Susquehanna Fundamental Investments
Pennsylvania
$45K +$65.8K +14,500 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$44K
AIG
29
American International Group
New York
$44K +$64.3K +14,173 New
CAN
30
Cetera Advisor Networks
California
$43K +$2.27K +500 +4%
State Board of Administration of Florida Retirement System
31
State Board of Administration of Florida Retirement System
Florida
$41K +$59.6K +13,150 New
VOYA Investment Management
32
VOYA Investment Management
Georgia
$40K +$59.3K +13,065 New
SG Americas Securities
33
SG Americas Securities
New York
$39K +$57K +12,576 New
Deutsche Bank
34
Deutsche Bank
Germany
$33K +$48.4K +10,668 New
Bank of America
35
Bank of America
North Carolina
$31K +$28.8K +6,340 +170%
UBS Group
36
UBS Group
Switzerland
$30K -$1.32M -290,545 -97%
JP Morgan Chase
37
JP Morgan Chase
New York
$24K +$35.4K +7,795 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$18K +$27.2K +6,000 New
Carson Wealth (CWM LLC)
39
Carson Wealth (CWM LLC)
Nebraska
$17K
CG
40
Cutler Group
California
$14K +$3.17K +700 +18%
Osaic Holdings
41
Osaic Holdings
Arizona
$14K +$11K +2,429 +105%
Citigroup
42
Citigroup
New York
$10K +$13.2K +2,910 +970%
Legal & General Group
43
Legal & General Group
United Kingdom
$10K +$14.8K +3,258 New
AIP
44
Ameritas Investment Partners
Nebraska
$6K +$9.28K +2,047 New
TRCT
45
Tower Research Capital (TRC)
New York
$4K -$3.17K -698 -38%
RWB
46
RMR Wealth Builders
New Jersey
$3K +$4.54K +1,000 New
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$2.67K +$3.94K +868 New
AWM
48
AllSquare Wealth Management
New York
$1K
JG
49
Jefferies Group
New York
$308 +$90.7K +20,000 +25%
Renaissance Technologies
50
Renaissance Technologies
New York
-$2.69M -653,759 Closed

FLNA Hedge Fund Activity: Q2 2020 in Review

51 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2020, worth a combined $18.2M — down 27% from $24.8M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new FLNA positions and 12 closed out — a net gain of 11 holders — while 17 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $5.36M. The largest seller was Bleichroeder LP, cutting an estimated $3.13M.

  • 51 institutional investors held Filana Therapeutics (FLNA) as of Q2 2020, up from 40 in Q1 2020.
  • Funds reported $18.2M of Filana Therapeutics stock for Q2 2020, down 27% quarter-over-quarter.
  • 23 funds opened new Filana Therapeutics positions in Q2 2020 and 12 closed out, a net change of +11 holders.
  • The largest Filana Therapeutics buyer in Q2 2020 was BlackRock, an estimated $5.36M added.
  • The largest Filana Therapeutics seller in Q2 2020 was Bleichroeder LP, an estimated $3.13M sold.

Based on aggregated 13F filings for Q2 2020.